CD44 and liver cancer: On the other hand, the significant increase in the uptake of HA-decorated liposomes in Huh7 demonstrates that CD44 can improve liposome uptake in aggressive liver cancer cells, making it a specific and suitable receptor for targeted drug delivery with liposomes that can distinguish between liver cancer cell lines and healthy hepatic cells.